Catalyst Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Catalyst Capital Advisors's LLY Position: Q3 2026 in Review
Catalyst Capital Advisors increased its Eli Lilly (LLY) stake by 435% in Q3 2026, buying an estimated $3.13M and bringing the position to 3,265 shares worth $3.78M. The position accounts for 0.06% of the portfolio, ranked #81.
Catalyst Capital Advisors first reported a position in LLY in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.66M in Q2 2014. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Catalyst Capital Advisors held 3,265 shares of Eli Lilly worth $3.78M as of Q3 2026.
- Catalyst Capital Advisors bought 2,655 Eli Lilly shares in Q3 2026, an estimated $3.13M.
- Eli Lilly made up 0.06% of Catalyst Capital Advisors's portfolio in Q3 2026, its #81 holding.
- Catalyst Capital Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 15 quarters since.
- Catalyst Capital Advisors's Eli Lilly position peaked at $8.66M in Q2 2014.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Catalyst Capital Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.